Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$0.63 - $1.14 $65,577 - $118,663
104,091 New
104,091 $86,000
Q2 2023

Aug 14, 2023

BUY
$1.31 - $2.04 $51,852 - $80,747
39,582 New
39,582 $63,000
Q4 2022

Feb 14, 2023

SELL
$2.02 - $3.25 $40,165 - $64,623
-19,884 Closed
0 $0
Q3 2022

Feb 14, 2023

BUY
$1.96 - $3.14 $38,972 - $62,435
19,884 New
19,884 $40,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.